![Marcus Yeo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marcus Yeo
Algemeen Directeur bij DefiniGEN Ltd.
Actieve functies van Marcus Yeo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DefiniGEN Ltd.
![]() DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Algemeen Directeur | - | - |
Oprichter | - | - |
Loopbaan van Marcus Yeo
Eerdere bekende functies van Marcus Yeo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
University of Oxford | Corporate Officer/Principal | - | - |
CN Bio Innovations Ltd.
![]() CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Operationeel
Chief Executive Officer | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Consumer Services | 2 |
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
CN Bio Innovations Ltd.
![]() CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Health Technology |
DefiniGEN Ltd.
![]() DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Beurs
- Insiders
- Marcus Yeo
- Ervaring